Aptose Biosciences
APTO
#10465
Rank
$4.36 M
Marketcap
$1.71
Share price
0.00%
Change (1 day)
755.00%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -$20.93 Million USD

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$25.23 Million USD, an increase over its 2023 earnings that were of -$52.36 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$20.93 Million-17.05%
2024 -$25.23 Million-51.82%
2023 -$52.36 Million22.9%
2022 -$42.61 Million-34.91%
2021 -$65.45 Million17.36%
2020 -$55.77 Million107.65%
2019 -$26.86 Million-7.73%
2018 -$29.11 Million160.68%
2017 -$11.17 Million-20.27%
2016 -$14.01 Million28.71%
2015 -$10.89 Million
2013 -$6.17 Million
2010 -$5.26 Million-8.31%
2009 -$5.73 Million
2006 -$10.63 Million-156.93%
2005 $18.65 M-185.16%
2004 -$21.91 Million458.58%
2003 -$3.93 Million-63.66%
2002 -$10.8 Million-8.04%
2001 -$11.74 Million16.73%
2000 -$10.06 Million294.99%
1999 -$2.55 Million-6.51%
1998 -$2.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-$34.03 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-$57.58 Million 175.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-$62.78 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA